Ignite Creation Date:
2025-12-25 @ 1:19 AM
Ignite Modification Date:
2026-01-28 @ 7:29 AM
Study NCT ID:
NCT05189093
Status:
RECRUITING
Last Update Posted:
2025-10-01
First Post:
2021-12-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Recombinant Humanized Anti-CD47/PD-1 Bifunctional Antibody HX009 in Patients With Relapsed/Refractory Lymphoma
Sponsor:
Organization: